BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7270940)

  • 1. [Immunological safety of blood transfusions. Present state of the problem (author's transl)].
    Habibi B
    Anesth Analg (Paris); 1981; 38(5-6):243-51. PubMed ID: 7270940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of ABO-incompatible transfusion].
    Fujii Y
    Masui; 2011 Jan; 60(1):47-54. PubMed ID: 21348250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological safety in blood transfusion. Current practical rules (author's transl)].
    Rouger P; Salmon C
    Anesth Analg (Paris); 1981; 38(11-12):679-83. PubMed ID: 7114520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion for patients with immunohematological problems].
    Tohyama H; Uchikawa M
    Rinsho Byori; 1982 Oct; 30(10):1089-95. PubMed ID: 6763640
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inconvenience of planned prophylaxis of transfusion-induced alloimmunization to red cells in chronic renal insufficiency].
    Habibi B; Lecolier B
    Rev Fr Transfus Immunohematol; 1983 Jun; 26(3):267-77. PubMed ID: 6415799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Limited indications for phenotyped blood in the prevention of transfusion-induced anti-red blood cell alloimmunization in chronic kidney failure].
    Habibi B; Lecolier B
    Nephrologie; 1983; 4(6):279-82. PubMed ID: 6669188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 13. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alloimmunization occurring after blood transfusions in gravid women (author's transl)].
    Busová M
    Cesk Gynekol; 1979 Jun; 44(5):327-31. PubMed ID: 110469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Emergency compatible, ABO-different blood group transfusion in the operating theater: a survey in regional Japanese Society of Anesthesiologists-certified training hospitals in 2006].
    Irita K; Inada E; Tsuzaki K; Inaba S; Handa M; Kino S; Mashiko K; Kubo T; Morita K
    Masui; 2009 Aug; 58(8):1045-54. PubMed ID: 19702231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The risk of post-transfusion hemolytic complications in rhesus-positive patients and the ways of their prevention].
    Dizik GM; Pavliuk RP
    Klin Khir; 2011 Sep; (9):69-72. PubMed ID: 22168031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemolytic transfusion reactions due to multiple alloantibodies including anti-E, anti-c and anti-Jkb.
    Park TS; Kim KU; Jeong WJ; Kim HH; Chang CL; Chung JS; Cho GJ; Lee EY; Son HC
    J Korean Med Sci; 2003 Dec; 18(6):894-6. PubMed ID: 14676451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titres of alloantibodies against A and B blood types in non-pedigree domestic cats in Turkey: assessing the transfusion reaction risk.
    Gurkan M; Arikan S; Ozaytekin E; Dodurka T
    J Feline Med Surg; 2005 Oct; 7(5):301-5. PubMed ID: 15914059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
    Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
    Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.